ORAMED PHARMACEUTICALS INC. (ORMP) Files Proxy Statement Ahead of Shareholder Meeting
Filing Details ORAMED PHARMACEUTICALS INC. (NASDAQ:ORMP) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on August 03, 2026. The…
Read more
